PlanPhilly Archive

The city recently determined that the Leibert House is “imminently dangerous.” It’s unclear if its owners will move to repair the property.

The $7.1 billion plan contains many of Mayor Cherelle Parker’s housing priorities, but none of the staffing requests made by elected officials.

Amid an affordable housing crisis, the Philadelphia Housing Authority is spending billions to expand its portfolio of subsidized units.

The bill is part of a broader effort to increase the capacity of the Fair Housing Commission, which is responsible for policing a variety of renter protections.

Elected officials and residents gathered Monday for a groundbreaking ceremony on the 1600 block of West Venango Street.

Advocates say additional staffing would enable employees to prepare more cases for administrative hearings, positioning the agency to make more rulings.

The Agriculture Resource Center in West Fairmount Park will lend tools and offer free skills workshops.

Amid a shortage of senior housing, the project will bring deeply affordable apartments for older adults and new homeownership opportunities to the neighborhood.

Henry Tetlow helped shape America’s cosmetics industry with more affordable — less caustic — face powders before his company collapsed into a family feud.

Named after Good Shepherd Presbyterian Church, which once occupied the site, the building addresses a critical need for affordable housing.

Fair housing advocates hope the decision empowers more tenants to speak out in a city where fears of retaliation run deep.

Customers, advocates and experts outlined the limited tools the city has to control costs during a hearing on rising utility bills.

Starting in early July, the vast portfolio of properties can be marketed to the general public. Housing advocates fear that could displace thousands.

The Turn the Key program promised affordable homeownership. Critics say many residents are priced out, raising the question: Who is "affordable housing" for?

The company plans to manufacture a rare, radioactive isotope for use in cancer treatment trials starting in 2029.